The Cystic Fibrosis Foundation is inviting Letters of Intent for its Clinical Pilot and Feasibility Award.
Through the program, grants of up to $80,000 (plus 12 percent for indirect costs) a year for up to two years will be awarded in support of efforts to collect enough preliminary data to determine the best strategies and methods for approaching a major question in CF that ultimately will require assessment through larger-scale research and/or a multi-center clinical trial.
Special consideration will be given to projects that pursue new approaches, under-researched topics, or more creative avenues of research to address the problems of cystic fibrosis. Applications for continued funding of the same project, or for long-term support of an investigator, will not be considered.
Applications may address any topic area advancing CF care, treatment, or research; however, applications addressing the following areas are encouraged: respiratory microorganism detection and treatment; gastrointestinal symptoms (including but not limited to gastroesophageal reflux disease (GERD), Distal Intestinal Obstruction Syndrome (DIOS), and pancreatitis); reducing treatment burden; CF-related diabetes; diet and nutrition; mental health; CF-related liver disease; exercise; sinus disease; allergies and asthma in CF; alternative/holistic treatments and therapies; sexual reproductive health; bone/joint health; and pain management.
To be eligible, applicants must be an independent investigator, defined by the foundation as an individual who is out of fellowship training and whose institution allows them to submit applications for research funding as a principle investigator. Citizens of the United States and applicants from outside the United States are welcome to apply.